Health e News
The arrival of the first batch of ARVs in June, 2005, at Madwaleni Hospital, in the rural area of Mbashe outside Mthatha, in the Eastern Cape, changed how health-care workers and the community view AIDS.
A single dose of two antiretrovirals given to mothers shortly after giving birth has shown to reduce the chances of the women developing later resistance, a new study from Zambia has shown.
The health indicators, which provide a snapshot of our nation’s health, still paint a picture of a violent, racially divided country where women bear the brunt of disease.
Traditional medicine generates almost R3-billion a year and government needs to urgently remove barriers preventing its practitioners from claiming from medical schemes for services rendered.
Whether it’s to test a vaccine or a microbicide to reduce HIV risk, clinical trials rely heavily on the goodwill of people. Without them, such trials won’t take place. But what motivates people to want to be part of these trials?
South Africa is sitting on a ‘future time bomb’ as employers remove medical health insurance from employees when they retire.
While hospital beds in the public sector are being reduced, the private sector has added almost 7 000 beds between 1998 and 2006.
Compulsory health insurance could be an effective way of dealing with problems in the private sector and addressing disparities between public and private health sectors.
The introduction of public-private partnerships (PPPs) in South Africa has been one of the more significant health care reforms in recent years, accelerating the efficient delivery of health care services at costs that are affordable.
The private sector is putting pressure on government to allow it to operate private medical schools.
The recent announcement about the failure of the leading AIDS vaccine candidate developed by Merck & Co. is another in a series of disappointing setbacks in HIV prevention. How we as a global community choose to respond to this news, however, is the real test.
An HIV vaccine is possible, but it will take some time before it’s discovered, says the head of the HIV/AIDS Research Unit at the National Institute for Communicable Diseases, Prof. Lynn Morris.
